#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary hypophosphataemic rickets Testicular leiomyosarcoma Gastrointestinal stromal tumour Thyroid cancer metastatic Amyloidosis Dent's disease Cushing's syndrome Porphyria non-acute Hypereosinophilic syndrome Autoimmune myositis Arterial tortuosity syndrome Endometrial cancer Fibrous dysplasia of bone Autoimmune demyelinating disease Urea cycle disorder More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency – Basic Information Familial amyotrophic lateral sclerosis – Trials in Disease Retinitis pigmentosa – Life with Disease Choroid melanoma Marginal zone lymphoma refractory – Basic Information Bronchopulmonary dysplasia Angiosarcoma recurrent – Life with Disease Rhabdomyosarcoma – Treatment Langerhans’ cell histiocytosis – Treatment Acquired haemophilia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Indometacin Vortioxetine Hydrobromide Glipizide Cart45Ra-Nkg2D Cells Gsk4381562A Chlortalidone Tisotumab Vedotin Autologous Microfat Regn5668 Betaxolol Cefalexin Monohydrate His203-Crm197 VINBLASTINE Sar-443579 Omx-0407 Ipn01194 Onasemnogene Abeparvovec Lisocabtagene Maraleucel Indacaterol Cipepofol More therapies…

    Learn about Your Condition

    Head and neck cancer stage III Agitation postoperative Hepatocellular carcinoma Cardiac failure congestive Plasmablastic lymphoma Stress Underweight Ovarian cancer recurrent Lung adenocarcinoma Chronic hepatitis B Gastrectomy Rabies Myasthenia gravis Basal cell carcinoma Glomerulonephritis acute More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Cyclophosphamide Monohydrate
    • Diphenhydramine Hydrochloride
    • Fludarabine Phosphate Ph. Eur.
    Austria Belgium Czechia Denmark France Germany +6

  • Study on the Safety and Effectiveness of LT3001 for Patients with Acute Ischemic Stroke

    Not recruiting

    2 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Lt3001
    Czechia Germany Greece Italy Portugal Spain

  • Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Leflunomide
    • Hydroxychloroquine Sulfate
    • Betamethasone
    Austria Belgium Bulgaria Cyprus Czechia Denmark +13

  • Study on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Germany Hungary Italy The Netherlands +4

  • Study on the Safety and Effectiveness of Furmonertinib vs. Platinum-Based Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • N-[2-[2-(Dimethylamino)Ethyl-Methylamino]-5-[[4-(1-Methylindol-3-Yl)Pyrimidin-2-Yl]Amino]-6-(2,2,2-Trifluoroethoxy)Pyridin-3-Yl]Prop-2-Enamide
    France Italy The Netherlands Spain

  • Study on Zetomipzomib for Patients with Active Lupus Nephritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Water For Injection
    • Zetomipzomib
    • Methylprednisolone Sodium Succinate
    Croatia France Germany Greece Italy Portugal +1

  • Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Fluocinolone Acetonide
    • Triamcinolone
    • Pimecrolimus
    Austria Belgium Bulgaria Croatia Czechia Finland +12

  • Study on the Safety and Effectiveness of CRN04894 for Patients with Congenital Adrenal Hyperplasia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • Crn04894
    • Fludrocortisone
    • Hydrocortisone
    Germany Italy

  • Study of Atezolizumab, Bevacizumab, and Tiragolumab for Patients with Untreated Advanced or Metastatic Liver Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Tiragolumab
    Belgium France Germany Italy Poland Spain

  • Study Comparing Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndrome Who Are Not Dependent on Blood Transfusions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Luspatercept
    • Epoetin Alfa
    Czechia France Germany Greece Hungary Italy +2
Previous Page
1 … 57 58 59 60 61 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!